Articoli anno 2006-2007

 

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
Ju-Seog Lee et all
.
Nature Medice 2006

A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma.
Min-Shan Chen et all.
Annals of Surgery 2006

An oncolytic adenovirus controlled by a modified Telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.
Sergai Bortolanza et all.

Cancer incidence in people with hepatitis B or C infection A large community-based linkage study.
Janaki Amin et all.
Journal of Hepatology. 2006

Capecitabine for Treatment of Advanced Hepatocellular Carcinoma.
von Delius S, Lersch C, Mayr M, Stock K, Schulte-Frohlinde E, Schmid RM,
Eckel F. 2006

Chronic Inflammation Associated with Hepatitis C Virus Infection Perturbs Hepatic Transforming Growth Factor beta Signaling, Promoting Cirrhosis and Hepatocellular Carcinoma.
Koichi Matsuzaki, Miki Murata, Katsunori Yoshida, Go Sekimoto, Yoshiko Uemura, Noriko Sakaida,
Hepatology. 2007

Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PETCT initial results.
Patrick Veit, Gerald Antoch, Hrvoje Stergar, Andreas Bockisc, Michael Forsting.
Eur Radiol. 2006

Diagnosis of Hepatic Nodules 20 mm or Smaller in Cirrhosis Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma.
Alejandro Forner, Ram´on Vilana, Carmen Ayuso, Lluý´s Bianchi, Manel Sol´e, Juan Ram´on Ayuso et all.
Hepatology. 2007

Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion.
K. K. Ng, R. T. Poon, C. M. Lam, J. Yuen, W. K. Tso and S. T. Fan

British Journal of Surgery 2006

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma a randomised multicentre phase III study.
G Verset, C Verslype, H Reynaert, I Borbath, P Langlet, A Vandebroek, M Peeters, G Houbiers,S Francque, M Arvanitakis and J-L Van Laethem.
British Journal of Cancer.2007

Genetic mutation in hepatic adenoma Seeing is believing.
Pei-Jer Chen.
Journal of Hepatology. 2006

Genotype–Phenotype Correlation in Hepatocellular Adenoma New Classification and Relationship With HCC.
Jessica Zucman-Rossi, Emmanuelle Jeannot, Jeanne Tran Van Nhieu, Jean-Yves Scoazec et all.
Hepatology. 2006

Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
Chien-Hung Chena, Guan-Tarn Huanga, Pei-Ming Yanga, Pei-Jer Chen et all.
European Journal of Cancer. 2006

Hepatocellular Carcinoma and Sex.
Jack Wands.
N Engl J Med. 2007

Hepatocellular carcinoma microwave ablation with multiple straight and loop antenna clusters pilot comparison with pathologic findings.
Nam C. Yu,David S. K. Lu, Steven S. Raman, Damian E. Dupuy, Caroline J. Simon, Charles Lassman,MD
Bassam I. Aswad,David Ianniti, Ronald W. Busuttil.
Radiology. 2006

Identification and Characterization of Tumorigenic Liver Cancer StemProgenitor Cells 2007.
Stephanie Ma et all.
Gastroenterology. 2007

Immunotherapy of hepatocellular carcinoma.
Tim F. Greten, Michael P. Manns, Firouzeh Korangy.
Journal of Hepatology. 2006

Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis.
Pierre Nahon et all.

Gastroenterology. 2008 in press

Nodular regenerative hyperplasia The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
Georgia Malamut, Marianne Ziol, Felipe Suarez, Michel Beaugrand.
Journal of Hepatology. 2008

Percutaneous Radiofrequency Thermal Ablation for Hepatocellular Carcinoma lights and shadows.
A. Baldan, D. Marino, M. De Giorgio, C. Angonese, U. Cillo, A. D’Alessandro, A. Masotto, M. Massani, M. Mazzucco, E. Miola, D. Neri, D. Paccagnella, G. Pivetta, A. Stellato, L. Tommasi, F. Tremolada, A. Tufano, G. Zanus, F. Farinati & On behalf of GENE – GRUPPO EPATOCARCINOMA NORD-EST
.
Aliment Pharmacol Ther. 2006

Phase 2 Study of Erlotinib in Patients With Unresectable Hepatocellular Carcinoma.
Melanie B. Thomas, Romil Chadha, Katrina Glover, Xuemei Wang, Jeffrey Morris, Thomas Brown, Asif Rashid, Janet Dancey, James L
.
Cancer. 2007

Postoperative recurrence in hepatocellular carcinoma Comparison between percutaneous ethanol injection and radiofrequency ablation.
Kaoru Iwata, Tetsuro Sohda, Shinya Nishizawa, Hidetoshi Nakane, Makoto Yoshikane, Yasuhiro Koyama, Daisuke Morihara, Yasuaki Takeyama, Yuko Uehara, Yuji Kitamura, Makoto Irie, Satoshi Syakadou, Masanori Yokoyama, Seiichiro Kamimura, Hiroshi Watanabe, Shotaro Sakisaka.
Arch Surg. 2006

Radiofrequency Ablation of Liver Tumors.
LM. Sutherland, JAR. Williams, RTA. Padbury, DC. Gotley, B Stoke, GJ. Maddern.
Arch Surg. 2006

Reviews in basic and clinical gastroenterology.
El–Serag H. and Lenhard Rudolph K.
Gastroenterology. 2007

Safety of Percutaneous Ethanol Injection as Neoadjuvant Therapy for Hepatocellular Carcinoma in Waiting List Liver Transplant Candidates.
J.F. Castroagudý´n, M. Delgado, A. Villanueva, M. Bustamante, J. Martý´nez, E. Otero, S. Tomé,
S.M. Martý´nez, F.R. Segade, R. Conde, E. Dominguez-Muñoz and E. Varo.
Transplantation Proceedings. 2005

Southern Europe as an example of interaction between various environmental factors a systematic review of the epidemiologic evidence.
F. Donato, U. Gelatti, R.M. Limina and G. Fattovich.
Oncogene. 2006

Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter.
Huang YH, Wu JC, Chen SC, Chen CH, Chiang JH, Huo TI, Lee PC, Chang FY, Lee SD.
Aliment Pharmacol Ther. 2006

Systematic review evidence-based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials.
P. M. Lopez, A. Villanueva & J. M. Llovet.
Aliment Pharmacol Ther. 2006

TACE-2 A phaseII III randomised double blinded placebo-controlled trial of sorafenib in combination with transarterial cheomoembolisation in hepatocellular cancer.
Trial Development Group: T.Meyer, D.Brant, A.Burroughs, J.Garden, P.Johnson, D.Palmer, J.Primrose, D.Stocken.
2007

The Bcl-2 apoptotic switch in cancer development and therapy.
JM Adams and S Cory.
Oncogene. 2007

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
JF Perz, GL Armstrong, LA Farrington, YJF Hutin, BP Bell.
Journal of Hepatology. 2006

The Effect of Menatetrenone, a Vitamin K2 Analog, on Disease Recurrence and Survival in Patients with Hepatocellular Carcinoma after Curative Treatment.
T Mizuta, I Ozaki, Y Eguchi, T Yasutake, S Kawazoe, K Fujimoto, K Yamamoto.
Cancer. 2006

The Oscar-worthy role of Myc in apoptosis.
Natalie Meyer, Sam S. Kim, Linda Z. Penn.
Seminars in Cancer Biology. 2006

Viral hepatitis and liver cancer the case of hepatitis C.
M Levrero.
Oncogene. 2006

 

Home

Chi siamo Faq Links Reviews News E-mail Casi clinici Immagini